Search
Neurosense Therapeutics Ltd
NRSNAdd to Watchlist
0.465USD
-0.011-2.27%
Close 07-31 16:00（ET）Quotes delayed by 15 min
16.44MMarket Cap
LossP/E TTM
NRSN Financials
See Neurosense Therapeutics Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Neurosense Therapeutics Ltd Earnings Date
Latest Release
Mar 31, 2026
EPS / Forecast
-0.44/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-0.44
20.46%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its current assets were 778.00K, with a year-on-year change of -82.33.
What are the total assets of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its total assets of Neurosense Therapeutics Ltd were 1.03M, with a year-on-year change of -77.53.
What are the total liabilities of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its total liabilities of Neurosense Therapeutics Ltd were 2.59M, with a year-on-year change of 29.92.
What is the total equity of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its total equity of Neurosense Therapeutics Ltd was -1.56M, with a year-on-year change of -160.39.
What is the net operating income of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its net operating income of Neurosense Therapeutics Ltd was -11.09M, with a year-on-year change of -11.95.
What is the net investment of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its net investment of Neurosense Therapeutics Ltd was -8.00K, with a year-on-year change of -900.00.
What is the net financing of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its net financing of Neurosense Therapeutics Ltd was 4.43M, with a year-on-year change of -59.39.
What is the Earnings Per Share (EPS) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.44, with a year-on-year change of 20.46.
What is the net income of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its net income was -11.12M, with a year-on-year change of -8.96.
What is the Return on Equity (ROE) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its Return on Equity (ROE) was -2174.98, with a year-on-year change of 12.23.
What is the Return on Assets (ROA) of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its Return on Assets (ROA) was -397.11, with a year-on-year change of -50.91.
What is the operating profit of Neurosense Therapeutics Ltd?
According to Neurosense Therapeutics Ltd's FY2025 earnings report, its operating profit was -11.09M, with a year-on-year change of -11.95.